Hina BudhwaniOctober 24, 2025

FDA 483 - Hina Budhwani - October 24, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Hina Budhwani

Record Details

An FDA inspection of Hina S. Budhwani, MD, Clinical Investigator in Houston, TX, revealed one observation related to the conduct of an investigation. The firm failed to adhere to the investigational plan by not maintaining the required waiting period between doses for subjects in a clinical protocol. This indicates a deviation from established study procedures.

Company: Hina Budhwani
Inspection Date: October 24, 2025
Product Type: Drugs
Office: Dallas District Office
Person: Habacuc V. Barrera

Open in Dashboard

ID · 4dc5ffd6-1b0f-44f5-b4de-f7a557b7eea6